Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.
Decay-accelerating factor (DAF, CD55) is a glycophosphatidyl inositol-anchored glycoprotein that regulates the activity of C3 and C5 convertases. In addition to understanding the mechanism of complement inhibition by DAF through structural studies, there is also an interest in the possible therapeut...
Principais autores: | White, J, Lukacik, P, Esser, D, Steward, M, Giddings, N, Bright, JR, Fritchley, S, Morgan, B, Lea, S, Smith, G, Smith, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2004
|
Registros relacionados
-
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli
por: White, J, et al.
Publicado em: (2004) -
Complement regulation at the molecular level: the structure of decay-accelerating factor.
por: Lukacik, P, et al.
Publicado em: (2004) -
Structural studies on decay accelerating factor and other complement regulators
por: Lukacik, P, et al.
Publicado em: (2001) -
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
por: Harris, C, et al.
Publicado em: (2005) -
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55)
por: Harris, C, et al.
Publicado em: (2005)